Health Care [ 4/12 ] | Biotechnology [ 18/72 ]
NASDAQ | Common Stock
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development.
The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease.
It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.
The company was incorporated in 2012 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 24 | -0.41 Decreased by -57.73% | - |
| Feb 28, 24 | -0.05 Increased by +91.90% | -0.38 Increased by +86.58% |
| Nov 13, 23 | -0.03 Increased by +92.14% | -0.37 Increased by +90.86% |
| Aug 14, 23 | -1.39 Decreased by -156.87% | -0.34 Decreased by -307.97% |
| May 15, 23 | -0.26 Increased by +44.68% | -0.56 Increased by +53.57% |
| Mar 21, 23 | -0.63 Increased by +7.35% | -0.46 Decreased by -36.96% |
| Nov 10, 22 | -0.43 Increased by +8.51% | -0.48 Increased by +10.42% |
| Aug 5, 22 | -0.54 Increased by +6.90% | -0.48 Decreased by -12.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | 763.20 K Increased by +124.10% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.09 M Decreased by -7.84% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -1.45 M Increased by +55.96% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | 4.48 M Increased by +205.81% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -3.17 M Decreased by -8.21% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -3.80 M Decreased by -65.50% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -3.28 M Decreased by -4.06% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -4.24 M Decreased by -42.91% | Decreased by N/A% Decreased by N/A% |